Journal of Lung Cancer Epidemiology

Aims And Scope

Journal of Lung Cancer Epidemiology (JLCE) is an open access, peer-reviewed international journal dedicated to the understanding, prevention, and treatment of cancer of the lungs. The journal covers a wide range of topics in the epidemiology of lung cancer, including the etiology of the disease, the public health implications, and the clinical implications of its diagnosis and treatment. Submitted manuscripts should contain original research reports, reviews, systematic and meta-analysis, and case reports in the field of lung cancer epidemiology. 

The main purpose of JLCE is to provide up-to-date evidence-based data for the prevention, diagnosis, treatment and prognosis of lung cancer. The journal also provides a platform for researchers to share their findings and insights concerning the etiology, epidemiology, and clinical and public health aspects of the disease. The journal strives to highlight the role of epidemiology, including descriptive, analytic and clinical research in understanding the etiology, prevalence, and risk factors associated with lung cancer.

The scope of JLCE provides a comprehensive review of the epidemiology of lung cancer, including all aspects of molecular epidemiology, cancer genetics, risk factors and clinical implications of genetic testing, biomarker research, and cancer prevention strategies. epidemiologic assessment of occupational and environmental carcinogens. The journal provides details about the incidence, risk factors, diagnosis, treatment, and prognosis in several countries and regions. By understanding and analyzing the evolving pattern in lung cancer epidemiology, the journal ultimately serves to increase public awareness and guide clinicians in better management of the disease.

The journal also covers the, with an emphasis on the role of occupational and environmental risk factors in the development, progression, and recurrence of lung cancer. JLCE is committed to the advancement of scientific knowledge in the field of epidemiology and aims to contribute to the progress of research in this area. It also encourages collaborations between scientists, clinicians, and public health professionals to promote excellence in research and evidence-based practice. 

The editorial team encourages manuscripts from all relevant disciplines, including but not limited to 

• squamous cell carcinoma
• Oncology
• Lymphocytes
• Lung cancer
• mesothelioma
• Adenocarcinoma
• Public health
• Symptoms of Lung Cancer
• Oxidative phosphorylation
• small cell lung cancer
• Molecular biology
• Biostatistics
• Non-Small Cell Lung Cancer
• Lung Cancer Staging
• Squamous cell cancer
• e-cigarettes
• lung health
• Allied medical sciences
• Incidence and mortality
• Radiotherapy and Chemotherapy
• Lung cancer incidence
• Lung cancer mortality
• Lung cancer survival
• Lung cancer screening
• Lung cancer risk factors
• Smoking and lung cancer
• Secondhand smoke and lung cancer
• Occupational exposure and lung cancer
• Environmental exposure and lung cancer
• Genetics and lung cancer
• Biomarkers for lung cancer
• Early detection of lung cancer
• Lung cancer staging
• Lung cancer treatment
• Surgery for lung cancer
• Radiation therapy for lung cancer
• Chemotherapy for lung cancer
• Immunotherapy for lung cancer
• Targeted therapy for lung cancer
• Palliative care for lung cancer
• Lung cancer clinical trials
• Lung cancer prevention
• Lung cancer awareness
• Lung cancer education
• Lung cancer disparities
• Lung cancer epidemiology
• Lung cancer incidence trends
• Lung cancer mortality trends
• Lung cancer survival rates
• Lung cancer screening guidelines
• Lung cancer screening eligibility
• Lung cancer screening adherence
• Lung cancer screening controversies
• Lung cancer risk assessment
• Lung cancer risk reduction
• Lung cancer risk communication
• Lung cancer risk perception
• Lung cancer prevention policies
• Lung cancer treatment decision-making
• Lung cancer treatment outcomes
• Lung cancer treatment complications
• Lung cancer survivorship

Eventually, the journal hopes to bridge the gap between the research, clinical, and public health communities by providing a platform for the dissemination of new findings and evidence-based practice. The journal aims to promote new discoveries and developments in the field of lung cancer and to encourage the translation of discoveries and evidence into clinical practice.